Zerhouni Moves Up At Sanofi-Aventis To President Of Global R&D
This article was originally published in The Pink Sheet Daily
Executive Summary
Former NIH director drafted by Viehbacher in early 2009 to be his science advisor replaces Cluzel as R&D chief.
You may also be interested in...
Sanofi Says Au Revoir To Viehbacher, But Is It Committing A Faux Pas?
The French pharma's abrupt dismissal of its CEO, citing execution problems with its best-selling drug and issues with management style, has investors wondering whether Chris Viehbacher should have gotten the benefit of the doubt from the company’s board, given his impressive track record.
Sanofi R&D Head Zerhouni Says Global Body For Health Care Is Needed
Drug development and regulation needs to be addressed on a world basis by a supranational entity that could be similar to WTO for trade, a Sanofi exec believes.
Sanofi R&D Head Zerhouni Says Global Body For Health Care Is Needed
Drug development and regulation needs to be addressed on a world basis by a supranational entity that could be similar to WTO for trade, Sanofi exec believes.